Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.

By L. Park-Wyllie, P. Mazzotta, A. Pastuszak, M. Moretti, Lizanne Beique, L. Hunnisett, M. Friesen, S. Jacobson, S. Kasapinovic, Debra Chang and 5 more. Teratology, 2000

909 citations recorded by the source corpus.

Subfields: Genetics, Public Health, Environmental and Occupational Health, Rheumatology

View Paper: https://www.semanticscholar.org/paper/2ffe77397e3c83b9640b4a87feeecfb32ab6c5d1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. U. Beuers
2. P. Invernizzi
3. K. Boberg
4. C. Mowat
5. D. Jones
6. M. Trauner
7. R. Chapman
8. O. Chazouilleres

Citations in the corpus

• EASL Clinical Practice Guidelines: management of cholestatic liver diseases. (2009, background): “The use of prednisolone is considered safe during pregnancy and lactation, but is associated with an increased risk of cleft palate in children to women using the drug in the first trimester [211].”
• Guidelines for the management of inflammatory bowel disease in adults (2011, background): “Corticosteroids vary in their ability to cross the placenta; 88% of prednisolone is deactivated to a less active metabolite as it crosses the placenta resulting in low fetal blood concentrations. If administration is prolonged or repeated in pregnancy there is a risk of intra-uterine growth retardat”